IVI in the Media
어린이조선일보 | “코로나19 종식됐지만 새 감염병 또 덮칠지도 지속적인 대비 필요해”
South China Morning Post | The latest coronavirus boosters target Omicron. Are they safe and effective?
Financial News | IVI Director General Jerome Kim: ‘Bill Gates a strong advocate of IVI’
South China Morning Post | Scientists urge people to take second Covid vaccine booster if offered as Omicron continues to spread
Financial Times | Unvaccinated and unprepared, North Korea faces Covid catastrophe
Chosun Ilbo | Jerome Kim, Director General of International Vaccine Institute, named a distinguished professor at Seoul National University
Financial Times | South Korea downgrades Covid to a ‘Class 2’ disease and removes restrictions
South China Morning Post | China was the world’s biggest Covid-19 vaccine exporter. Not any more
The Wall Street Journal | Despite High Covid-19 Case Counts, Asian Nations Learn to Live With the Virus
Barron’s | China Eases Some Covid Testing Rules. It’s a Targeted Approach to Reduce Impact on the Economy.
CNBC | We need to treat Covid as an endemic pathogen and update vaccines: International Vaccine Institute
Financial Times | Beijing digs in to avoid repeating Hong Kong’s Covid mistakes
The Telegraph | Why China and Hong Kong face a devastating new Covid wave
CGTN | Why is China seeing a surge in COVID-19 cases?
Financial Times | Shanghai teeters on the brink of Covid lockdown
ADB Insight | Year of the Vaccine: The Next Steps for Asia and the Pacific to Combat COVID-19
Fortune | Will we all need fourth COVID vaccine booster shots?
The Telegraph | South Korea abandons its successful test and trace system as omicron cases surge
South China Morning Post | Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?
The Guardian | Cuba leads the world in vaccinating children as young as two against Covid
The Telegraph | Vaccine hesitancy among Taiwan’s elderly mars its pandemic performance and prevents reopening
Director General Jerome Kim on The Alex Salmond Show
South China Morning Post | Which vaccines stop Omicron? Search for data moves from labs to real world
CNBC | 2022 will be the ‘year of vaccination,’ says director of vaccine institute
South China Morning Post | As Omicron upends Covid-19 vaccine targets, what will the future look like?
South China Morning Post | Omicron and the Winter Olympics – is China’s zero-Covid strategy up to the challenges?
CBS Mornings | With Omicron on its doorstep, countries in Asia are closing up
National Geographic | Omicron is dodging the immune system—but boosters show promising signs
Khaleej Times | Covid: 96% of people in low-income nations have yet to receive first vaccine dose, says expert
Voice of America | South Korea Showed How to Contain COVID, Now It Will Try to Live With It
China Daily | Experts say countries should remain cautious about reopening borders
South China Morning Post | Next Covid-19 test? Diagnostic blind spots stir visions of bleak midwinter
South China Morning Post | US-China coronavirus vaccine diplomacy heats up but can donations sway allegiances?
The New York Times | How Asia, Once a Vaccination Laggard, Is Revving Up Inoculations
South China Morning Post | Coronavirus: as rich countries turn to big-name booster shots from Pfizer, AstraZeneca, the poor are left with lesser-known rivals like Abdala, Soberana 2
South China Morning Post | Coronavirus: China seeks to develop next-gen vaccines amid trial complications
South China Morning Post | Can China stay ahead as a leading exporter of Covid-19 vaccines?
Maeil Business Newspaper | All music is beautiful in its own way, but Violinist Sang Hee Lee’s music shines a special light
Nature | Six months of COVID vaccines: what 1.7 billion doses have taught scientists
Asian Boss | We Asked Top Vaccine Expert About COVID Vaccine Problems
Bloomberg | Consequences of ‘Huge’ Global Gap in Vaccinations
EIU Perspectives | What does Denmark’s permanent suspension of both the AstraZeneca and Janssen covid-19 vaccines mean for other countries?
Asia Times | Vaccinations in a race against viral variants
Nature | Why COVID vaccines are so difficult to compare
DEVEX | Opinion: COVAX — too big, and too important, to fail
CNN | “Our response needs to be clear, strong, and unified”
South China Morning Post | Coronavirus vaccines will save 2021? Not so fast, here’s what the experts think
Bloomberg | Will the Covid-19 Vaccines Be Effective and Safe?
Asian Boss | Update On COVID-19 Vaccine Price & Schedule From A Leading Vaccine Expert
The Telegraph | ‘If you are not prepared, the virus has found every weakness’: How countries in Asia tamed Covid-19
CGTN | ‘The vaccine itself is not the silver bullet,’ says International Vaccine Institute
Devex | Q&A: Why Jerome Kim is ‘hopeful’ but cautious about distributing a COVID-19 vaccine
Maeil Business Newspaper | IVI Director General Jerome Kim Shares His Thoughts on Resurgence of COVID-19 Outbreaks in S. Korea
Chosun Ilbo | IVI Director General Jerome Kim Shares His Thoughts on Equitable Access of COVID-19 Vaccines
Channel News Asia | On a fast track like never before: The COVID-19 vaccine effort and 5 vital questions
The Economist’s Future of Healthcare Insight Hour | Vaccine development: A race to the finish line
Devex | Q&A: Is COVID-19 helping or hindering progress toward an HIV vaccine?
TED | The trials, tribulations and timeline of a COVID-19 vaccine
Wired Korea | The End of World War C: Peace without Victory?
Asian Boss | World’s Leading Vaccine Expert Fact-Checks COVID-19 Vaccine Conspiracy
Development Today | Why Sweden funds a vaccine institute in Korea and not Oslo-based CEPI
CNBC | Parts of Asia that relaxed restrictions without a resurgence in coronavirus cases did these three things
The Korea Herald | [Herald Interview] ‘Making vaccines accessible is biggest COVID-19 challenge’
CGTN: The Agenda with Stephen Cole | Speed of vaccine trials is ‘unprecedented’
Asian Boss | We Asked The World’s Leading Vaccine Expert About COVID-19 Vaccine
The Guardian | Test, trace, contain: how South Korea flattened its coronavirus curve
BBC World Service: The Inquiry | How do we come out of the lockdown? (13:00)
ANC 24/7 | Int’l Vaccine Institute: 12-18 months reasonable timetable for development of Covid-19 vaccine
Seeker | How Fast Can We Make a Coronavirus Vaccine?
Education City Speaker Series: Flattening the Curve – Global Responses to COVID-19
Wion News | About 70% of vaccines used around the world are made in India: S Korean expert Dr Jerome Kim
South China Morning Post | How long will a coronavirus vaccine take? A Q&A with Jerome Kim, head of the International Vaccine Institute
BBC World News | Jerome Kim: Vaccines are the long-term solution to the pandemic
The Korea Times | Developing vaccine against COVID-19
TRT: Bigger than Five | COVID-19: The World Reacts
South Korea’s fight against coronavirus (CBS News)
NDTV | Top South Korea Doctor On Why He Thinks Coronavirus Is Not A ‘Chinese Virus’
RTE | What South Korea can teach Ireland about fighting Covid-19
Physical distancing should last months, not weeks, says epidemiologist (Yahoo News Canada)
Development of vaccine requires massive investment… international cooperation is needed (Korea Economic Daily)
COVID-19 Pandemic (Arirang TV, 22:50~46:00)
By then, we’ll have a vaccine on our side (Hankyoreh—Korean)
Coronavirus Pandemic: International Vaccine Institute director on how long it will take to develop vaccine (CGTN)
Testing times: Why South Korea’s COVID-19 strategy is working (Al Jazeera English)
Genexine seeks to compress the vaccine timeline
Genexine, Binex to develop COVID-19 vaccine (Korea Biomedical Review)
Genexine, Binex to co-develop coronavirus vaccine GX-19 (Korea Herald)
How close are we to a COVID-19 vaccine? Jerome H. Kim from International Vaccine Institute (Arirang News)
COVID-19 vaccine, drugs on fast track for development: IVI chief (Yonhap News)
Inside the race to find a coronavirus vaccine (Devex)
Chinese students keen for turnaround (China Daily)
China Daily | S. Korea can try out makeshift hospitals, experts say
Director General Jerome Kim for Phoenix TV
Speed and accuracy vital for COVID-19 test kits (Arirang News)
2020 COVID-19 Live Updates: Jerome Kim for tbs eFM
Jerome Kim for KBS WORLD Radio, Korea24 on the COVID-19 outbreak in South Korea
Korea should join efforts in vaccine development to prevent pandemics (JoongAng Ilbo)
Future global health threats
IVI: COVID-19 could linger (Korean)
Jerome Kim for Korea, Factual: “Hong Kong’s handling of COVID-19 outbreak & Prospects of vaccine development”
Concerns about the spread of COVID-19: When will a vaccine be developed? When can we expect the “Super Vaccine”?
Al Jazeera English | Scientists call for global cooperation over coronavirus
When will COVID-19 vaccine be commercialized…And “super vaccine”? (Korean)
Global push to find vaccine against devastating bug growing
IVI receives $15.7 million to conduct Ph III trials of typhoid vaccine
Korean vaccines expanding global territory
Neglected Victims of Neglected Diseases
Let’s build a common defense against epidemics
Vaccine investment brings 16-fold return… partnering with Bill Gates
World must join forces to prevent infectious diseases
IVI editorial in The Korea Herald advocates for Korean leadership for global health
×
Total 94
| Number | Title | Author | Date | Votes | Views |
| 94 |
Vaccine investment brings 16-fold return... partnering with Bill Gates
ivi
|
2017.10.23
|
Votes 0
|
Views 7205
|
ivi | 2017.10.23 | 0 | 7205 |
| 93 |
World must join forces to prevent infectious diseases
ivi
|
2017.05.15
|
Votes 0
|
Views 9286
|
ivi | 2017.05.15 | 0 | 9286 |
| 92 |
IVI editorial in The Korea Herald advocates for Korean leadership for global health
ivi
|
2017.04.28
|
Votes 0
|
Views 5118
|
ivi | 2017.04.28 | 0 | 5118 |
| 91 |
Most dengue infections transmitted in and around home
ivi
|
2017.04.04
|
Votes 0
|
Views 4873
|
ivi | 2017.04.04 | 0 | 4873 |
| 90 |
Discussing borderless private- public partnerships to achieve the target of developing 17 new drugs by 2020
ivi
|
2016.10.10
|
Votes 0
|
Views 6232
|
ivi | 2016.10.10 | 0 | 6232 |
| 89 |
A global roadmap for MERS-CoV research and product development published in Nature Medicine
ivi
|
2016.10.10
|
Votes 0
|
Views 5637
|
ivi | 2016.10.10 | 0 | 5637 |
| 88 |
Challenges in MenB vaccine development
ivi
|
2016.10.10
|
Votes 0
|
Views 5794
|
ivi | 2016.10.10 | 0 | 5794 |
| 87 |
IVI at International Scientific Expert Meeting on Typhoid Fever in Madagascar
ivi
|
2016.10.10
|
Votes 0
|
Views 5669
|
ivi | 2016.10.10 | 0 | 5669 |
| 86 |
IVI on Arirang TV’s “Upfront”
ivi
|
2016.10.10
|
Votes 0
|
Views 5383
|
ivi | 2016.10.10 | 0 | 5383 |
| 85 |
Single dose oral cholera vaccination study featured in SciDev.Net
ivi
|
2016.10.10
|
Votes 0
|
Views 5424
|
ivi | 2016.10.10 | 0 | 5424 |